Transgenomic to Acquire Clinical Data's Genetic Test Business for $15.4M
November 30, 2010
Transgenomic to Acquire Clinical Data's Genetic Test Business for $15.4M
The assets being acquired include 11 Familion tests as well as contracts with private and government health insurers for test reimbursement through policies offering access to genetic testing for an estimated 280 million patients.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Clinical Data Completes Sale of Genetic, PGx Test Business to Transgenomic
December 30, 2010 / GenomeWeb Daily News - Transgenomic, Amgen Ink Deal to Develop Test for KRAS, NRAS
May 6, 2013 / GenomeWeb Daily News - Medicare to Cover Transgenomic's Test for Plavix
July 24, 2012 / GenomeWeb Daily News - Transgenomic Scoops Up Clinical Data's Genetic Tests, PGx Products at 'Fair Price' of $15.4M
December 1, 2010 / Pharmacogenomics Reporter - Medco Boosts Personalized Medicine Efforts with DNA Direct Acquisition
February 3, 2010 / GenomeWeb Daily News